- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02344459
Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening
January 16, 2015 updated by: Kara Hoppe, University of Washington
Randomized Controlled Trial: Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening
The purpose of this study is to perform a randomized controlled trial to compare the efficacy of 80mL double balloon catheter versus a 30mL single catheter balloon for pre-induction cervical ripening by evaluating the change in Bishop score.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
105
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Bishop score of 5 or less
- Singleton
- Cephalic presentation
- Fewer than 4 contractions in 10 minutes
- Reactive fetal monitoring
Exclusion Criteria:
- Non-vertex presentation
- Placenta previa
- Vasa previa
- Unexplained vaginal bleeding
- Active herpes simplex virus infection
- Non-English speaking
- Previous attempt at an induction of labor in the current pregnancy
- Prolapsed umbilical cord
- More than one prior cesarean delivery or history of classical cesarean delivery
- Patients receiving or planning to undergo exogenous prostaglandin administration as the primary induction agent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 80mL double balloon catheter (Cook catheter®)
|
The balloon catheters have been used to provide mechanical dilation to the cervix as a method of pre-induction cervical ripening.
|
|
Active Comparator: 30mL single Foley balloon catheter
|
The balloon catheters have been used to provide mechanical dilation to the cervix as a method of pre-induction cervical ripening.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Bishop score greater than or equal to 6 at time of balloon catheter removal
Time Frame: until catheter removal (12 hours maximum)
|
until catheter removal (12 hours maximum)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
induction to delivery time
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
vaginal delivery time less than 24 hours from initiation of induction
Time Frame: 24 hours
|
24 hours
|
|
|
mode of delivery
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
Time to catheter expulsion
Time Frame: Up to 12 hours
|
Up to 12 hours
|
|
|
Type of catheter expulsion
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
spontaneous vs. provider
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
Epidural utilization
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
Meconium stained amniotic fluid
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
5 minute Apgar score
Time Frame: The participants infant will be monitored from immediately to 5 minutes after birth
|
The participants infant will be monitored from immediately to 5 minutes after birth
|
|
|
Medication required to augment labor
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
prostaglandins, oxytocin
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
Artificial rupture of membranes required to augment labor
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
Cesarean section indications
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
Neonatal intensive care unit admissions
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
Chorioamnionitis
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
|
|
birthweight
Time Frame: The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kara K Hoppe, DO, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
January 16, 2015
First Posted (Estimate)
January 26, 2015
Study Record Updates
Last Update Posted (Estimate)
January 26, 2015
Last Update Submitted That Met QC Criteria
January 16, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 36685-D
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-induction Cervical Ripening
-
Aalto UniversityHelsinki University Central Hospital; Tampere University Hospital; Jyväskylä...Not yet recruitingInduction of Labor | Cervical Ripening | Cervical Ripening and Induction of LaborFinland
-
Aalto UniversityUniversity of Minnesota; University of Mississippi Medical CenterNot yet recruitingCervical Ripening | Induction of Birth | Cervical Ripening and Induction of Labor
-
Aalto UniversityUniversity of Minnesota; University of Mississippi Medical CenterNot yet recruitingCervical Ripening | Induction of Birth | Balloon Catheter for Labor Induction | Cervical Ripening and Induction of Labor
-
Ferring PharmaceuticalsCompletedCervical Ripening | Labor InductionUnited Kingdom
-
Università degli Studi dell'InsubriaCompletedCervical Ripening | Labor InductionItaly
-
Weill Medical College of Cornell UniversityCompletedCervical Ripening | Labor InductionUnited States
-
Mahidol UniversityCompletedCervical Ripening | Labor InductionThailand
-
University of Alabama at BirminghamCompletedCervical Ripening | Labor InductionUnited States
-
Western Galilee Hospital-NahariyaNot yet recruitingInduction of Labor | Cervical Ripening
-
University of OklahomaFerring PharmaceuticalsCompletedInduction of Labor | Cervical RipeningUnited States
Clinical Trials on mechanical pre-induction cervical ripening
-
EgymedicalpediaNot yet recruitingInduction of Labor | Post DateEgypt
-
Etlik Zubeyde Hanım Women's Health Care, Training...Completed
-
Etlik Zubeyde Hanım Women's Health Care, Training...CompletedCervical Ripening | Pregnancy, High-RiskTurkey
-
University Hospital, ToursCompleted
-
MemorialCare Health SystemCompletedPatient Satisfaction | Induction of Labor Affected Fetus / Newborn | Cervical RipeningUnited States
-
Western Galilee Hospital-NahariyaNot yet recruitingInduction of Labor | Cervical Ripening
-
Aalto UniversityHelsinki University Central Hospital; Tampere University Hospital; Jyväskylä...Not yet recruitingInduction of Labor | Cervical Ripening | Cervical Ripening and Induction of LaborFinland
-
University of Alabama at BirminghamCompleted
-
University of Roma La SapienzaNot yet recruiting
-
National University of MalaysiaCompleted